Abnormal "Escherichia Shigella-EAT-LAAD" axis in HFrEF patients with AF and the regulatory effect of SGLT2 inhibitors.

Han JM, Zhu FY, Niu XH, Hu JF, Fan SM, Ying ZH, Ma YL

Open source

DOI
10.3389/fcvm.2026.1872678
Published
2026
Container
Frontiers in cardiovascular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2026.1872678,
  title = {Abnormal "Escherichia Shigella-EAT-LAAD" axis in HFrEF patients with AF and the regulatory effect of SGLT2 inhibitors.},
  author = {Han JM and Zhu FY and Niu XH and Hu JF and Fan SM and Ying ZH and Ma YL},
  year = {2026},
  journal = {Frontiers in cardiovascular medicine},
  doi = {10.3389/fcvm.2026.1872678},
  url = {https://doi.org/10.3389/fcvm.2026.1872678}
}

RIS

TY  - JOUR
TI  - Abnormal "Escherichia Shigella-EAT-LAAD" axis in HFrEF patients with AF and the regulatory effect of SGLT2 inhibitors.
AU  - Han JM
AU  - Zhu FY
AU  - Niu XH
AU  - Hu JF
AU  - Fan SM
AU  - Ying ZH
AU  - Ma YL
PY  - 2026
JO  - Frontiers in cardiovascular medicine
DO  - 10.3389/fcvm.2026.1872678
UR  - https://doi.org/10.3389/fcvm.2026.1872678
ER  - 

APA

JM, H., FY, Z., XH, N., JF, H., SM, F., ZH, Y., & YL, M. (2026). Abnormal "Escherichia Shigella-EAT-LAAD" axis in HFrEF patients with AF and the regulatory effect of SGLT2 inhibitors.. Frontiers in cardiovascular medicine. https://doi.org/10.3389/fcvm.2026.1872678

Source records